Enhancer-gene regulatory interactions in colorectal cancer revealed through genome-wide CRISPRi perturbations
<ns5:p>Background Establishing functional relationships between distal enhancers and their target genes is a central challenge in genome biology and cancer genetics. CRISPR/dCas9-mediated perturbations followed by single-cell RNA sequencing (Perturb-seq) has emerged as an efficient means of establishing enhancer-target gene relationships. Results We used genome-wide CRISPRi Perturb-seq with 35,139 guide RNAs targeting 12,117 enhancers to create a functional enhancer-gene map of colorectal cancer (CRC), identifying 238 significant regulatory associations (FDR < 0.1). Integration of chromatin accessibility (ATAC-seq), histone modification profiling (ChIP-seq), and ultra-high resolution chromatin conformation capture (Micro-C) data revealed that enhancer regulation in CRC is constrained by topological domains and often targets the nearest gene, findings corroborated by Activity-by-Contact modelling. Conclusions We present here a comprehensive, genome-scale functional atlas of enhancer-gene associations in CRC. This resource should provide a foundation for studying gene regulation in colorectal tumorigenesis and for prioritising candidate non-coding drivers in cancer sequencing studies.</ns5:p>
Authors
- Richard S. Houlston (ORCID: https://orcid.org/0000-0002-5268-0242)
- Philip Law (ORCID: https://orcid.org/0000-0001-9663-4611)
- Jayaram Vijayakrishnan (ORCID: https://orcid.org/0000-0002-8284-2249)
- Maria Mandelia (ORCID: https://orcid.org/0000-0001-7571-6669)
- Timothy Barry
- James Smith
- Eugene Katsevich
Institutions
- Harvard University (US)
- Institute of Cancer Research (GB)
- Cancer Research And Biostatistics (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Wellcome Open Research
- Published
- 2026-07-30
- DOI
- https://doi.org/10.12688/wellcomeopenres.26913.1
- Primary Topic
- Genomics and Chromatin Dynamics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Cancer Research UK